Johnson & Johnson (NYSE:JNJ)
| 165.75 Delayed Data As of Oct 26 |  +1.67 / +1.02%Today’s Change | 133.65 Today|||52-Week Range 179.92 | +5.32% Year-to-Date |
Latest JNJ News | Press Releases
Today’s Trading
| Previous close | 164.08 |
| Today’s open | 164.66 |
| Day’s range | 164.06 - 166.05 |
| Volume | 6,939,057 |
| Average volume (3 months) | 6,107,517 |
| Market cap | $431.0B |
Data as of 5:51pm ET, 10/26/2021
Growth & Valuation
| Earnings growth (last year) | -2.22% |
| Earnings growth (this year) | +22.42% |
| Earnings growth (next 5 years) | +6.15% |
| Revenue growth (last year) | +0.56% |
| P/E ratio | 24.9 |
| Price/Sales | 5.09 |
| Price/Book | 6.81 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PFEPfizer | +0.42 | +0.97% |
| LLYEli Lilly and Co | +3.37 | +1.38% |
| MRKMerck | +0.57 | +0.70% |
| ABBVAbbVie | +1.00 | +0.92% |
Data as of 5:09pm ET, 10/26/2021
Financials
| Next reporting date | January 25, 2022 |
| EPS forecast (this quarter) | $2.16 |
| Annual revenue (last year) | $82.6B |
| Annual profit (last year) | $14.7B |
| Net profit margin | 17.82% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New Brunswick, New Jersey |
Forecasts
